A Randomized Control Trial Comparing Linjeta Versus Humalog in Pumps: Effect on Postprandial Blood Sugars.
Withdrawn before enrolling · Phase 2
Conditions studied: Diabetes Mellitus
In brief
The purpose of this study is to determine if the use of Linjeta(tm) insulin when compared to Humalog will result in significantly lower episodes of hyperglycemia and hypoglycemia after a breakfast meal.
Key facts
- Study ID
- NCT01067118
- Run by
- Stanford University
- People needed
- 0
- Starts
- 2010-04-01
- Expected to finish
- 2011-06-01
- Last updated by the study team
- 2017-02-10
Who can join
Age: 18 and older, up to 50. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Stanford University School of Medicine — Stanford, California, United States
- University of Colorado Denver School of Medicine Barbara Davis Center — Denver, Colorado, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.